The estimated Net Worth of Alan D Frazier is at least $27.1 Milione dollars as of 24 February 2004. Alan Frazier owns over 260,416 units of Rigel Pharmaceuticals stock worth over $25,513,819 and over the last 21 years Alan sold RIGL stock worth over $1,617,668.
Alan has made over 5 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Alan sold 2,332 units of RIGL stock worth $44,541 on 24 January 2005.
The largest trade Alan's ever made was exercising 260,416 units of Rigel Pharmaceuticals stock on 24 February 2004 worth over $1,499,996. On average, Alan trades about 28,837 units every 28 days since 2003. As of 24 February 2004 Alan still owns at least 1,967,141 units of Rigel Pharmaceuticals stock.
You can see the complete history of Alan Frazier stock trades at the bottom of the page.
Alan's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke e Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: